产品中心 抗体 其他一抗

所有图片(1/8)

LIN28B Recombinant Rabbit mAb (S-2360-117)

Protein lin-28 homolog B,Lin-28B,CSDD2

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6204
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    LIN28B
  • 分子别名

    Protein lin-28 homolog B; Lin-28B; CSDD2
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cytoplasm, Nucleus
  • Accession

    Q6ZN17
  • 克隆号

    S-2360-117
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu
  • 阳性样本

    HepG2, K562, HEK-293, JAR
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    ICC ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000-1:5000 Hu
    IHC-P 1:1000 Hu
    ICC 1:500 Hu
背景介绍
  • LIN28B is an evolutionarily-conserved RNA-binding protein that acts as a potent developmental timing regulator and oncofetal factor by selectively binding and blocking the biogenesis of let-7 family microRNAs, thereby relieving repression of pluripotency, cell-cycle, and metabolic genes; it is predominantly expressed during embryogenesis and in many cancers, where its overexpression promotes self-renewal, metabolic reprogramming, and aggressive phenotypes through both let-7–dependent and independent mechanisms, including direct stabilization of IGF2, HMGA1, and MYC mRNAs and activation of the PI3K/AKT/mTOR and WNT/β-catenin pathways, making LIN28B a critical driver of oncogenesis, stemness, and resistance to therapy across diverse tumor types.

  • 免疫印迹

    • WB result of LIN28B Recombinant Rabbit mAb
      Primary antibody: LIN28B Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: HepG2 whole cell lysate 20 µg
      Lane 2: K562 whole cell lysate 20 µg
      Lane 3: HEK-293 whole cell lysate 20 µg
      Lane 4: JAR whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 27 kDa
      Observed MW: 33 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human placenta. Anti-LIN28B antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human testis. Anti-LIN28B antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded human kidney. Anti-LIN28B antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 免疫细胞化学

    • ICC shows positive staining in K562 cells. Anti-LIN28B antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • ICC shows positive staining in HepG2 cells. Anti-LIN28B antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

  • 组织表达图谱

    • Expression of LIN28B in tumor tissue.

    • Expression of LIN28B in human tissue.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)